CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)

被引：0
|
作者：
Leschenko, Y. [1 ]
Chebotareva, T. [1 ]
Spizhenko, N. [1 ]
Fedusenko, A. [1 ]
Sharaevskiy, O. [1 ]
Buryk, V. [1 ]
机构：
[1] Cyber Knife, Cyber Clin Spizhenko, Kapitanivka, Kyiv Region, Ukraine
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1155
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [21] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER: A COMPARISON OF PATIENTS WITH AND WITHOUT PATHOLOGICAL PROOF
    Verstegen, Naomi E.
    Lagerwaard, Frank J.
    Haasbeek, Cornelis J.
    Slotman, Ben
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S281 - S282
  • [22] Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard
    Yalman, Deniz
    Selek, Ugur
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (11)
  • [23] A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC)
    Lee, Katherine
    Le, Tue
    Hau, Eric
    Hanna, Gerard G.
    Gee, Harriet
    Vinod, Shalini
    Dammak, Salma
    Palma, David
    Ong, Anselm
    Yeghiaian-Alvandi, Roland
    Buck, Jacqueline
    Lim, Rebecca
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (01): : 40 - 59
  • [24] Is stereotactic ablative radiotherapy (SABR) clinically suitable in early stage non-small cell lung cancer (NSCLC) patients with WHO performance status (PS) 3?
    Hassani, A.
    Pickles, R.
    Mackenzie, L.
    McCallum, H.
    Turnbull, H.
    Atherton, P.
    Iqbal, M. S.
    LUNG CANCER, 2018, 115 : S58 - S58
  • [25] Use of Stereotactic Ablative Radiotherapy (SABR) in Non-Small Cell Lung Cancer Measuring More Than 5 cm
    Tekatli, Hilal
    van't Hof, Saar
    Nossent, Esther J.
    Dahele, Max
    Verbakel, Wilko F. A. R.
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (06) : 974 - 982
  • [26] Stereotactic ablative radiotherapy (SABR) in medically inoperable early stage non-small cell lung cancer (NSCLC): A single tertiary UK centre experience
    Yip, C.
    Landau, D. B.
    Thomas, C.
    Ahmad, S.
    LUNG CANCER, 2013, 79 : S58 - S58
  • [27] Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach
    Agolli, Linda
    Valeriani, Maurizio
    Nicosia, Luca
    Bracci, Stefano
    De Sanctis, Vitaliana
    Minniti, Giuseppe
    Enrici, Riccardo Maurizi
    Osti, Mattia Falchetto
    ANTICANCER RESEARCH, 2015, 35 (11) : 6239 - 6245
  • [28] Introduction of stereotactic ablative body radiotherapy (SABR) for early stage non-small cell Lung cancer (NSCLC) at a tertiary referral centre - the Birmingham experience
    Stevenson, R.
    Cook, M.
    Webster, G.
    Brennan, M.
    Stange, D.
    Wingate, E.
    Biard, C.
    Hickman, M.
    Ghafoor, Q.
    LUNG CANCER, 2014, 83 : S62 - S62
  • [29] Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer: Rationale and Outcomes
    Iyengar, Puneeth
    Timmerman, Robert D.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (12): : 1514 - 1520
  • [30] STEREOTACTIC ABLATIVE RADIOTHERAPY OF EARLY STAGE NON-SMALL CELL LUNG CANCER
    Cvek, Jakub
    Feltl, David
    Knybel, Lukas
    Otahal, Bretislav
    Skacelikova, Eva
    Binarova, Andrea
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S537 - S537
12345